135 related articles for article (PubMed ID: 35836181)
1. Modest effect of statins on fasting glucose in a longitudinal electronic health record based cohort.
Haldar T; Oni-Orisan A; Hoffmann TJ; Schaefer C; Iribarren C; Krauss RM; Medina MW; Risch N
Cardiovasc Diabetol; 2022 Jul; 21(1):132. PubMed ID: 35836181
[TBL] [Abstract][Full Text] [Related]
2. Effect of statins on fasting glucose in non-diabetic individuals: nationwide population-based health examination in Korea.
Kim J; Lee HS; Lee KY
Cardiovasc Diabetol; 2018 Dec; 17(1):155. PubMed ID: 30518364
[TBL] [Abstract][Full Text] [Related]
3. The Risk of Muscular Events Among New Users of Hydrophilic and Lipophilic Statins: an Observational Cohort Study.
Mueller AM; Liakoni E; Schneider C; Burkard T; Jick SS; Krähenbühl S; Meier CR; Spoendlin J
J Gen Intern Med; 2021 Sep; 36(9):2639-2647. PubMed ID: 33751411
[TBL] [Abstract][Full Text] [Related]
4. Comparative risk of lipophilic and hydrophilic statins on incident depression: A retrospective cohort study.
Dave CV; Winterstein AG; Park H; Cook RL; Hartzema AG
J Affect Disord; 2018 Oct; 238():542-546. PubMed ID: 29936394
[TBL] [Abstract][Full Text] [Related]
5. Differences in the diabetogenic effect of statins in patients with prediabetes. The PRELIPID study.
Trias F; Pintó X; Corbella E; Suárez-Tembra M; Ruíz-García A; Díaz-Díaz JL; Sánchez-Ruíz-Granado E; Sarasa I; Martínez-Porqueras R; Rodríguez-Sánchez MA; Corbella X;
Med Clin (Barc); 2022 Jun; 158(11):531-539. PubMed ID: 34517987
[TBL] [Abstract][Full Text] [Related]
6. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
7. Differences between statins on clinical endpoints: a population-based cohort study.
Dieleman JP; van Wyk JT; van Wijk MA; van Herpen G; Straus SM; Dunselman H; Sturkenboom MC
Curr Med Res Opin; 2005 Sep; 21(9):1461-8. PubMed ID: 16197665
[TBL] [Abstract][Full Text] [Related]
8. Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase.
Gupta A; Thompson D; Whitehouse A; Collier T; Dahlof B; Poulter N; Collins R; Sever P;
Lancet; 2017 Jun; 389(10088):2473-2481. PubMed ID: 28476288
[TBL] [Abstract][Full Text] [Related]
9. An examination of the effect of cytochrome P450 drug interactions of hydroxymethylglutaryl-coenzyme A reductase inhibitors on health care utilization: a Canadian population-based study.
Einarson TR; Metge CJ; Iskedjian M; Mukherjee J
Clin Ther; 2002 Dec; 24(12):2126-36. PubMed ID: 12581550
[TBL] [Abstract][Full Text] [Related]
10. Time-varying and dose-dependent effect of long-term statin use on risk of type 2 diabetes: a retrospective cohort study.
Na E; Cho S; Kim DJ; Choi J; Han E
Cardiovasc Diabetol; 2020 May; 19(1):67. PubMed ID: 32416728
[TBL] [Abstract][Full Text] [Related]
11. Development of reusable logic for determination of statin exposure-time from electronic health records.
Miller AW; McCarty CA; Broeckel U; Hytopoulos V; Cross DS
J Biomed Inform; 2014 Jun; 49():206-12. PubMed ID: 24637142
[TBL] [Abstract][Full Text] [Related]
12. Use of Statins and the Risk of Incident Diabetes: A Retrospective Cohort Study.
Olotu BS; Shepherd MD; Novak S; Lawson KA; Wilson JP; Richards KM; Rasu RS
Am J Cardiovasc Drugs; 2016 Oct; 16(5):377-90. PubMed ID: 27272032
[TBL] [Abstract][Full Text] [Related]
13. Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.
Heintjes EM; Penning-van Beest FJ; Plat AW; Meerding WJ; Webb K; Sturkenboom MC; Herings RM
Pharmacotherapy; 2012 Jul; 32(7):631-41. PubMed ID: 22760692
[TBL] [Abstract][Full Text] [Related]
14. Statin prescribing in the elderly in the Netherlands: a pharmacy database time trend study.
Geleedst-De Vooght M; Maitland-van der Zee AH; Schalekamp T; Mantel-Teeuwisse A; Jansen P
Drugs Aging; 2010 Jul; 27(7):589-96. PubMed ID: 20583852
[TBL] [Abstract][Full Text] [Related]
15. Comparisons of effects of statins (atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjects.
Schaefer EJ; McNamara JR; Tayler T; Daly JA; Gleason JL; Seman LJ; Ferrari A; Rubenstein JJ
Am J Cardiol; 2004 Jan; 93(1):31-9. PubMed ID: 14697462
[TBL] [Abstract][Full Text] [Related]
16. Statins and new-onset diabetes: a retrospective longitudinal cohort study.
Ma T; Tien L; Fang CL; Liou YS; Jong GP
Clin Ther; 2012 Sep; 34(9):1977-83. PubMed ID: 22939164
[TBL] [Abstract][Full Text] [Related]
17. Effect of SLCO1B1 T521C on Statin-Related Myotoxicity With Use of Lovastatin and Atorvastatin.
Lu B; Sun L; Seraydarian M; Hoffmann TJ; Medina MW; Risch N; Iribarren C; Krauss RM; Oni-Orisan A
Clin Pharmacol Ther; 2021 Sep; 110(3):733-740. PubMed ID: 34114646
[TBL] [Abstract][Full Text] [Related]
18. Statin therapy on glycemic control in type 2 diabetic patients: A network meta-analysis.
Cui JY; Zhou RR; Han S; Wang TS; Wang LQ; Xie XH
J Clin Pharm Ther; 2018 Aug; 43(4):556-570. PubMed ID: 29733433
[TBL] [Abstract][Full Text] [Related]
19. Effect of statins on fasting plasma glucose in diabetic and nondiabetic patients.
Sukhija R; Prayaga S; Marashdeh M; Bursac Z; Kakar P; Bansal D; Sachdeva R; Kesan SH; Mehta JL
J Investig Med; 2009 Mar; 57(3):495-9. PubMed ID: 19188844
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
